IDA Ireland

Beyond Cost: What Manufacturers Look for in Investment Locations

Since COVID, pharma manufacturers have shifted from lean, centralized supply chains toward regionalized hubs — balancing cost, flexibility, and geopolitical security to build resilience against future economic shocks.